C9304 HCPCS Level II Code: Injection, marstacimab-hncq, 0.5 mg
Coding at a Glance
- CMS cross-references
- 1 related code
Medicare Coverage & Payment
- CMS short descriptor: Inj marstacimab, 0.5 mg
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Pricing indicator: 53
- BETOS: O1E — Other drugs
- Last CMS action effective: July 1, 2025
- Terminated: June 30, 2025
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after July 1, 2025.
Change history
- July 1, 2025Removed from the code setInjection, marstacimab-hncq, 0.5 mg
- April 1, 2025Added to the code setInjection, marstacimab-hncq, 0.5 mg
Related Codes
CMS cross-reference: code to use instead
The CMS HCPCS Level II code set carries an explicit cross-reference from this code (deleted or not valid for Medicare) to this code. A cross-referenced code can itself have been retired since; a terminated target is marked.
Contextual Map
Every relationship of C9304 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (24)
- C9300 — Injection, indigotindisulfonate sodium, 1 mg[Sibling]
- C9301 — Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose[Sibling]
- C9302 — Injection, zanidatamab-hrii, 2 mg[Sibling]
- C9303 — Injection, zolbetuximab-clzb, 1 mg[Sibling]
- C9305 — Injection, nipocalimab-aahu, 3 mg[Sibling]
- C9306 — Injection, telisotuzumab vedotin-tllv, 1 mg[Sibling]
- C9307 — Injection, linvoseltamab-gcpt, 1 mg[Sibling]
- C9308 — Injection, carboplatin (avyxa), 1 mg[Sibling]
- and 16 more
CMS cross-reference
- J7172 — Injection, marstacimab-hncq, 0.5 mg[Cross-referenced to]
Change history (2)
- July 1, 2025 — Removed from the code set [Change history]
- and 1 more
Nearest Codes in This Family
Official HCPCS Level II classifications closest to C9304 in its code family, with their registry titles.
- C9300 — Injection, indigotindisulfonate sodium, 1 mg
- C9301 — Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9302 — Injection, zanidatamab-hrii, 2 mg
- C9303 — Injection, zolbetuximab-clzb, 1 mg
- C9305 — Injection, nipocalimab-aahu, 3 mg
- C9306 — Injection, telisotuzumab vedotin-tllv, 1 mg
- C9307 — Injection, linvoseltamab-gcpt, 1 mg
- C9308 — Injection, carboplatin (avyxa), 1 mg
- C9309 — Injection, onasemnogene abeparvovec-brve, per treatment
- C9310 — Injection, leucovorin calcium (avyxa), 1 mg